Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lululemon Athletica Inc (LULU) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Lululemon Athletica IncTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Lululemon Athletica Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Lululemon Athletica Inc trades at $94 (market cap $10.42B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Lululemon Athletica Inc and Dr. Reddy's Laboratories Ltd Common Stock are close in size by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Lululemon Athletica Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lululemon Athletica Inc for 106 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

LULURDY
Market Cap
$10.42B$10.61B
Volume
2,574,4193,738,869
Sector
Consumer CyclicalHealth
52-Week High
$215.88$15.38
52-Week Low
$91.88$11.38
Typical Hold Time
106 Days0 Days
Enterprise Value
$11.17B$10.51B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lululemon Athletica Inc

Lululemon stock trades at $94.34, near its 52-week low, reflecting a 54% decline year-to-date amid growth concerns and securities fraud investigations. The technical picture is bearish, with the stock below key moving averages. Fundamentally, the company maintains strong profitability with a 56.11% gross margin and 12.78% net margin, but revenue growth has slowed, and Q3 2026 earnings are pending. Analyst consensus is mixed, with a Hold rating predominant and a $97.67 price target.

The outlook is cautious due to competitive pressures, governance scrutiny, and potential legal liabilities. While valuation metrics like a P/E of 7.76 appear attractive, near-term risks from weakening fundamentals and negative sentiment may limit upside. Recovery hinges on reversing revenue trends and resolving legal overhangs, making the stock speculative for now.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LULU
29% Buy71% Sell
Avg holding period · 106 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Lululemon Athletica Inc

Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.

Read more on LULU →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →